Last reviewed · How we verify

NCT00699465

A Double-blind Randomized Trial to Compare the Efficacy of Intermittent Pneumatic Compression (IPC) With and Without Early Anticoagulant Treatment for Prevention of Venous Thromboembolism (VTE) in Patients With Acute Primary Intracerebral Hemorrhage (ICH)

Status unknown Phase 4 Last updated 1 July 2010
What this trial tests

Phase 4 trial testing enoxaparin in Intracerebral Hemorrhage in 320 participants. Status unknown.

Timeline
1 August 2008
Primary endpoint
1 July 2013
1 December 2013

Quick facts

Lead sponsorUniversity of Oulu
PhasePhase 4
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment320
Start date1 August 2008
Primary completion1 July 2013
Estimated completion1 December 2013
Sites1 location across Finland

Drugs / interventions tested

Conditions studied

Sponsor

University of Oulu

Who can join

18 and older, any sex, with Intracerebral Hemorrhage. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

* To evaluate the efficacy of using IPC during the acute phase of ICH in the prevention of VTE. * To assess the safety and efficacy of additional therapy with enoxaparin. * To compare the efficacy and safety of the European and American guideline recommendations. * To provide an efficient and safe thromboprophylaxis for several weeks until the patient is able to walk.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of enoxaparin

Trials testing the same drug.

Other recruiting trials for Intracerebral Hemorrhage

Currently open trials in the same condition.

Other University of Oulu trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00699465.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing